HOME > Others > Relert

Relert

  1. NAME OF THE MEDICINAL PRODUCT

RELERT 20 mg film-coated tablets

RELERT 40 mg film-coated tablets

 

  1. QUALITATIVE AND QUANTITATIVE COMPOSITION

RELERT 20 mg film-coated tablets

 

Each film-coated tablet contains 20 mg of eletriptan (as hydrobromide).

Excipients with known effect:

Each film-coated tablet contains 23 mg of lactose and 0.036 mg of orange-yellow aluminum lacquer.

 

 RELERT 40 mg film-coated tablets

 

Each film-coated tablet contains 40 mg of eletriptan (as hydrobromide).

Excipients with known effect:

Each film-coated tablet contains 46 mg of lactose and 0.072 mg of orange-yellow aluminum lacquer.

 

  1. PHARMACEUTICAL FORM

Film-coated tablets.

 

RELERT 20 mg film-coated tablets

Round, convex and orange tablets, engraved with "REP 20" on one side and "Pfizer" on the other side.

RELERT 40 mg film-coated tablets

Round, convex and orange tablets, engraved with "REP 40" on one side and "Pfizer" on the other side.

 

  1. INDICATIONS

Relert is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura, for adults.

 

  1. CLASSIFICATION FOR SUPPLY SYSTEM

Medicine provided with medical prescription. Refundable by the System

National Health: Normal Contribution.

Relert 20 mg film-coated tablets, 4 tablets PVP

IVA: 18.33€.

Relert 40 mg film-coated tablets, 4 tablets PVP

IVA: 29.33€.